TUBERCULOSIS BURDEN IN LEBANON: EVOLUTION AND CURRENT STATUS.

@article{Araj2016TUBERCULOSISBI,
  title={TUBERCULOSIS BURDEN IN LEBANON: EVOLUTION AND CURRENT STATUS.},
  author={G F Araj and Antoine Saad{\'e} and Lina Y. Itani and Aline Z. Avedissian},
  journal={Le Journal medical libanais. The Lebanese medical journal},
  year={2016},
  volume={64 1},
  pages={
          1-7
        }
}
BACKGROUND In the absence of surveillance data and consolidated information about tuberculosis (TB) and its drug resistance burden in Lebanon, this retrospective study was conducted to shed light on TB and its other relevant aspects over the last 15 years in this country. METHODS To generate the TB data for this retrospective study, two main sources were used: 1) the records of patients in the National Tuberculosis Program (NTP); 2) the results of the Clinical Microbiology Laboratory (CML) at… 
Non-tuberculous mycobacteria profiles and their anti-mycobacterial resistance at a major medical center in Lebanon.
TLDR
The revelaed different NTM species, with predominance of M.simiae and various AMR profiles provide a current epidemiologic database and help guiding the selection of appropriate empirical therapy once the clinical relevance is established.
Prevalence of tuberculosis and multidrug resistant tuberculosis in the Middle East Region
TLDR
This study analyzes data for 17 countries comprising the Middle East for estimated incidence of TB, number of notified TB cases, mortality rate, and rate of MDR-TB in new and previously treated TB cases as reported by WHO.
First insights on the genetic diversity of MDR Mycobacterium tuberculosis in Lebanon
TLDR
The population diversity in Lebanon holds an equally diverse and uncharacterized population of drug resistant mycobacteria and Lebanon must decrease TB incidences by 95% in the next decade to achieve the WHO “END-TB” milestones of 2025 and 2035.
An evaluation of a tuberculosis case-finding and treatment program among Syrian refugees—Jordan and Lebanon, 2013–2015
TLDR
IOM’s program of NTP support provides critical TB services for Syrian refugees with high treatment completion rates and thorough contact investigations need continued emphasis, including completely recording investigations in both countries, to find active TB cases.
Emergence of Mycobacterium simiae: A retrospective study from a tertiary care center in Lebanon
TLDR
The prevalence of multidrug resistance among the Lebanese M. simiae isolates is very high limiting the treatment options, and clofazimine was used in only two patients whose isolates were resistant to all but one agent.
An overview of tuberculosis and migration.
  • P. Dhavan, H. M. Dias, J. Creswell, D. Weil
  • Medicine, Political Science
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
  • 2017
TLDR
A framework for the prevention and reduction of the TB burden among migrants, adapted from the World Health Organization's End TB Strategy and in accordance with the Stop TB Partnership's Global Plan and the Sustainable Development Goals agenda is outlined.
Spoligotyping of Mycobacterium tuberculosis isolates using Luminex®-based method in Lebanon.
TLDR
This study is one of the first to describe the genomic diversity and epidemiology of MTB isolates of Lebanon, and suggests an increasing prevalence of SIT127 in the country.
Prevalence of latent tuberculosis infection in Syrian refugees to Canada
TLDR
The 9% (95% confidence interval 3–15%) prevalence of LTBI was higher than expected in this population of Syrian refugees arriving in Canada, and the prévalence of tuberculose was inconnue.
Epidemiological Study of Lung Cancer Incidence in Lebanon
TLDR
Lebanon has the highest incidence of LC in females and the second highest for males in the MENA region and when compared to countries in other regions of the world.
...
1
2
3
...

References

SHOWING 1-10 OF 35 REFERENCES
Nationwide study of drug resistance among acid-fast bacilli positive pulmonary tuberculosis cases in Lebanon.
  • G. Araj, M. Saadé, L. Itani
  • Medicine, Biology
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
  • 2006
TLDR
Relatively moderate single drug resistance and very low MDR rates were found among new TB cases, while among previously treated TB cases very high resistance and MDR resistance rates were detected, which underline the need for ongoing stringent control measures to curb the spread of M. tuberculosis.
Extensively drug-resistant tuberculosis
  • P. Lobue
  • Medicine, Biology
    Current opinion in infectious diseases
  • 2009
TLDR
The origin, epidemiology, diagnosis, treatment, prevention, and control of extensively drug-resistant tuberculosis (XDR TB), an emerging global health threat, is described.
MDR, XDR, TDR tuberculosis: ominous progression
TLDR
It is argued that India bears a disproportionately large burden of the world's TB, one a developing country can ill afford, with an estimated economic loss of US $43 billion and 100 million productive days lost annually directly due to this disease.
Comparative study of antituberculous drug resistance among Mycobacterium tuberculosis isolates recovered at the American University of Beirut Medical Center: 1996-1998 vs 1994-1995.
TLDR
This study shows a high prevalence and persistence of TB drug resistance tested in the Medical Center in Lebanon and the shift in the increase of resistance from one and two drugs to three and four drugs are very ominous and should be considered when treating patients in this country.
Prevalence of drug resistance in clinical isolates of tuberculosis from GCC: a literature review from January 2002 to March 2013.
TLDR
The study demonstrates that the prevalence of MDR-TB in GCC countries is almost equal to other developing and developed countries, and requires immediate attention for surveillance and control.
Burden and trends of hospitalisations associated with pulmonary non-tuberculous mycobacterial infections in Germany, 2005–2011
TLDR
Evidence is provided of a changing epidemiology of PNTM infections and highlights emerging clinical implications in Germany, where COPD is currently the most important associated condition.
Efficacy of BACTEC TB in the rapid confirmatory diagnosis of mycobacterial infections. A Lebanese tertiary care center experience.
TLDR
BACTEC is substantially more sensitive, efficient and rapid than LJ in the laboratory diagnosis of mycobacterial infections and provides an excellent facility for physicians in patient management and public health personnel for prompt initiation of infection control measures.
Global tuberculosis: perspectives, prospects, and priorities.
TLDR
The death rate associated with tuberculosis has decreased 45%, from 25 persons to 14/100 000 population, although rates vary widely between countries, and Mortality rates are declining, albeit slowly, in all regions of the world.
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study
TLDR
A snapshot of NTM species distribution demonstrates that the species distribution among NTM isolates from pulmonary specimens in the year 2008 differed by continent and differed by country within these continents.
...
1
2
3
4
...